ATANASIO
PANDIELLA ALONSO

Investigador

Foto de ATANASIO

Foto de Javier

Javier
León Serrano

Javier León Serrano-rekin lankidetzan egindako argitalpenak (5)

2021

JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
Biomedicine and Pharmacotherapy, Vol. 144

2018

Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia [Oncotarget, 8 (2017) (29679-29698)] Doi: 10.18632/oncotarget.11425
Oncotarget

2017

CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698
ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
Oncogene, Vol. 36, Núm. 12, pp. 1733-1744

2002

Mitogen-activated protein kinase routes as targets in the action of Diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells
Molecular Cancer Therapeutics, Vol. 1, Núm. 10, pp. 811-819